Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Bevacizumab and Retinal Vascular Occlusions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
Information provided by:
Asociación para Evitar la Ceguera en México Identifier:
First received: June 30, 2006
Last updated: July 3, 2006
Last verified: June 2006
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Condition Intervention Phase
Edema Macular
Vascular Occlusion
Drug: Intravitreal injection
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:

Further study details as provided by Asociación para Evitar la Ceguera en México:


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria:

  • Previous surgery
  • Uveitis
  • Glaucoma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00347711

Asociacion para Evitar la Ceguera en Mexico Recruiting
Mexico, D.F. Mexico, Mexico, 04030
Contact: Griselda Alvarez, Fellow    5255 10841400 ext 1171   
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Principal Investigator: Griselda Alvarez, Fellow APEC
  More Information Identifier: NCT00347711     History of Changes
Other Study ID Numbers: APEC-0020
Study First Received: June 30, 2006
Last Updated: July 3, 2006

Additional relevant MeSH terms:
Macular Edema
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases processed this record on May 23, 2017